Covered recipient · General Payments record
PAISLEE R DALTON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$865.03
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $280.14 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $58.36 | 3 |
| ABBVIE INC. | $34.01 | 2 |
| Amgen Inc. | $33.39 | 2 |
| Medtronic, Inc. | $32.74 | 2 |
| Mylan Specialty L.P. | $22.52 | 1 |
| Lundbeck LLC | $20.59 | 1 |
| Lilly USA, LLC | $16.81 | 1 |
| Xeris Pharmaceuticals, Inc. | $16.63 | 1 |
| Acerta Pharma LLC | $15.37 | 1 |
| GlaxoSmithKline, LLC. | $15.22 | 1 |
| Novo Nordisk AS | $14.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.53 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106981605 | CMS |
| ABBVIE INC. | $19.48 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106981607 | CMS |
| Amgen Inc. | $13.15 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117535646 | CMS |
| Amgen Inc. | $20.24 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117232791 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.37 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104772800 | CMS |
| GlaxoSmithKline, LLC. | $15.22 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116150655 | CMS |
| Lilly USA, LLC | $16.81 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135939508 | CMS |
| Lundbeck LLC | $20.59 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146010961 | CMS |
| Medtronic, Inc. | $15.99 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116920390 | CMS |
| Medtronic, Inc. | $16.75 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116920392 | CMS |
| Mylan Specialty L.P. | $22.52 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147316455 | CMS |
| Novo Nordisk Inc | $14.50 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100389735 | CMS |
| PFIZER INC. | $13.55 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131130577 | CMS |
| PFIZER INC. | $27.56 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131549194 | CMS |
| PFIZER INC. | $17.25 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131997703 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.63 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144636358 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.